Literature DB >> 6488686

Ketamine kinetics in unmedicated and diazepam-premedicated subjects.

E F Domino, S E Domino, R E Smith, L E Domino, J R Goulet, K E Domino, E K Zsigmond.   

Abstract

Plasma ketamine concentrations after diazepam and placebo pretreatment were examined in a double-blind, randomized, cross-over study. Eight healthy male subjects received either diazepam or a 0.9% NaCl placebo before ketamine and received the alternate combination 5 to 24 days later. Ten minutes before ketamine dosing, diazepam, 0.3 mg/kg, or placebo in equal volume was injected intravenously at a rate not exceeding 5 mg/min. Ketamine, 2.2 mg/kg iv, was injected over 1 min. For the clinically relevant period for anesthesia (1 to 30 min), diazepam-ketamine treatment resulted in higher plasma levels at most time points, but diazepam pretreatment did not alter plasma levels of metabolite KI and pseudometabolite KII nor the 24-hr urinary excretion of ketamine, KI, and KII. Ketamine kinetics followed a three-term exponential decline under both treatment conditions. After placebo-ketamine dosing, plasma t 1/2s were as follows: distribution (pi t 1/2) = 24.1 sec, redistribution (alpha t 1/2) = 4.68 min, and elimination (beta t 1/2) = 2.17 hr. After diazepam-ketamine dosing, t 1/2s were: pi t 1/2 = 25.0 sec, alpha t 1/2 6.37 min, and beta t 1/2 = 2.32 hr.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488686     DOI: 10.1038/clpt.1984.235

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  23 in total

1.  The effect of target-controlled infusion of low-dose ketamine on heat pain and temporal summation threshold.

Authors:  Joon-Ho Lee; Sung-Hwan Cho; Sang-Hyun Kim; Won-Soek Chae; Hee-Cheol Jin; Jeong-Seok Lee; Yong-Ik Kim
Journal:  J Anesth       Date:  2011-04-22       Impact factor: 2.078

2.  Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.

Authors:  Sargo Aalto; Jouni Ihalainen; Jussi Hirvonen; Jaana Kajander; Harry Scheinin; Heikki Tanila; Kjell Någren; Harry Vilkman; Lars L Gustafsson; Erkka Syvälahti; Jarmo Hietala
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

3.  Ketamine concentrations during cardiopulmonary bypass.

Authors:  R F McLean; A J Baker; S E Walker; C D Mazer; B I Wong; E M Harrington
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

4.  The use of Hickman-Broviac catheters for paediatric radiotherapy.

Authors:  C A Harrison; J Filshie
Journal:  Ann R Coll Surg Engl       Date:  1986-11       Impact factor: 1.891

Review 5.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

6.  Anaesthesia and monitoring for paediatric radiotherapy.

Authors: 
Journal:  J R Soc Med       Date:  1987-03       Impact factor: 5.344

Review 7.  Ketamine: review of its pharmacology and its use in pediatric anesthesia.

Authors:  S A Bergman
Journal:  Anesth Prog       Date:  1999

8.  Maternal awareness and neonatal outcome after ketamine induction of anaesthesia for Caesarean section.

Authors:  A Baraka; F Louis; R Dalleh
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

Review 9.  Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action.

Authors:  Eric A Maltbie; Gopinath S Kaundinya; Leonard L Howell
Journal:  Behav Pharmacol       Date:  2017-12       Impact factor: 2.293

Review 10.  Expanding Role of NMDA Receptor Antagonists in the Management of Pain.

Authors:  Denise Kreutzwiser; Qutaiba A Tawfic
Journal:  CNS Drugs       Date:  2019-04       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.